We are live on ! Find out more
ALXA

Alexza Pharmaceuticals Inc
ALXA

Delisted

ALXA was delisted on the 16th of June, 2016.

Back to rankings

0 hedge funds and large institutions have $0 invested in Alexza Pharmaceuticals Inc in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 25 → 0 (-25)

100% less capital invested

Capital invested by funds: $1.45M → $0 (-$1.45M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 25

Holders
–
Holders Change
-25
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
25
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$379K
2
CS
Credit Suisse
Switzerland
-$374K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$331K
4
Goldman Sachs
Goldman Sachs
New York
-$210K
5
CLOS
Compagnie Lombard Odier SCmA
Switzerland
-$72K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
– -$379K -782,689 Closed
CS
2
Credit Suisse
Switzerland
– -$374K -771,753 Closed
Vanguard Group
3
Vanguard Group
Pennsylvania
– -$331K -683,411 Closed
Goldman Sachs
4
Goldman Sachs
New York
– -$210K -432,822 Closed
CLOS
5
Compagnie Lombard Odier SCmA
Switzerland
– -$72K -150,000 Closed
Geode Capital Management
6
Geode Capital Management
Massachusetts
– -$44 -91,033 Closed
Bank of New York Mellon
7
Bank of New York Mellon
New York
– -$17K -35,767 Closed
Northern Trust
8
Northern Trust
Illinois
– -$13K -27,764 Closed
California Public Employees Retirement System
9
California Public Employees Retirement System
California
– -$13K -26,307 Closed
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
– -$13K -26,110 Closed
Citadel Advisors
11
Citadel Advisors
Florida
– -$10K -21,244 Closed
UBS Group
12
UBS Group
Switzerland
– -$7K -14,529 Closed
JP Morgan Chase
13
JP Morgan Chase
New York
– -$3K -7,076 Closed
BFA
14
BlackRock Fund Advisors
California
– -$2K -4,525 Closed
SA
15
SRH Advisors
Kansas
– -$2K -4,350 Closed
Bank of America
16
Bank of America
North Carolina
– -$1K -2,707 Closed
Creative Planning
17
Creative Planning
Kansas
– -$1K -2,150 Closed
Manulife (Manufacturers Life Insurance)
18
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$1K -2,067 Closed

ALXA Hedge Fund Activity: Q2 2016 in Review

0 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Alexza Pharmaceuticals Inc (ALXA) for Q2 2016, worth a combined $0 — down 100% from $1.45M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of ALXA and 0 opened new positions — a net loss of 25 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Morgan Stanley, exiting entirely with an estimated $379K sold.

  • 0 institutional investors held Alexza Pharmaceuticals Inc (ALXA) as of Q2 2016, down from 25 in Q1 2016.
  • Funds reported $0 of Alexza Pharmaceuticals Inc stock for Q2 2016, down 100% quarter-over-quarter.
  • 0 funds opened new Alexza Pharmaceuticals Inc positions in Q2 2016 and 25 closed out, a net change of -25 holders.
  • The largest Alexza Pharmaceuticals Inc seller in Q2 2016 was Morgan Stanley, an estimated $379K sold.

Based on aggregated 13F filings for Q2 2016.